111 related articles for article (PubMed ID: 9264367)
1. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60.
Zavadil J; Brezinová J; Svoboda P; Zemanová Z; Michalová K
Leukemia; 1997 Aug; 11(8):1187-92. PubMed ID: 9264367
[TBL] [Abstract][Full Text] [Related]
2. Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor.
Hejlik DP; Kottickal LV; Liang H; Fairman J; Davis T; Janecki T; Sexton D; Perry W; Tavtigian SV; Teng DH; Nagarajan L
Cancer Res; 1997 Sep; 57(17):3779-83. PubMed ID: 9288787
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene.
Dubourg C; Toutain B; Hélias C; Henry C; Lessard M; Le Gall JY; Le Treut A; Guenet L
Cancer Genet Cytogenet; 2002 Apr; 134(1):33-7. PubMed ID: 11996793
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia.
Jiang Y; Liang H; Guo W; Kottickal LV; Nagarajan L
Blood; 2000 Jun; 95(12):3945-50. PubMed ID: 10845932
[TBL] [Abstract][Full Text] [Related]
5. An antisense transcript to SMAD5 expressed in fetal and tumor tissues.
Zavadil J; Svoboda P; Liang H; Kottickal LV; Nagarajan L
Biochem Biophys Res Commun; 1999 Feb; 255(3):668-72. PubMed ID: 10049768
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4.
Fuchs O; Simakova O; Klener P; Cmejlova J; Zivny J; Zavadil J; Stopka T
Blood Cells Mol Dis; 2002; 28(2):221-33. PubMed ID: 12064918
[TBL] [Abstract][Full Text] [Related]
7. Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus.
Fairman J; Wang RY; Liang H; Zhao L; Saltman D; Liang JC; Nagarajan L
Blood; 1996 Sep; 88(6):2259-66. PubMed ID: 8822947
[TBL] [Abstract][Full Text] [Related]
8. SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma.
Zimonjic DB; Durkin ME; Keck-Waggoner CL; Park SW; Thorgeirsson SS; Popescu NC
Neoplasia; 2003; 5(5):390-6. PubMed ID: 14670176
[TBL] [Abstract][Full Text] [Related]
9. Construction of a yeast artificial chromosome contig encompassing the human acidic fibroblast growth factor (FGF1) gene: toward the cloning of the ANLL/MDS tumor-suppressor gene.
Chiu IM; Gilmore EC; Liu Y; Payson RA
Genomics; 1994 Feb; 19(3):552-60. PubMed ID: 7514571
[TBL] [Abstract][Full Text] [Related]
10. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
[TBL] [Abstract][Full Text] [Related]
11. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome.
Nagarajan L; Zavadil J; Claxton D; Lu X; Fairman J; Warrington JA; Wasmuth JJ; Chinault AC; Sever CE; Slovak ML
Blood; 1994 Jan; 83(1):199-208. PubMed ID: 8274735
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates.
Wu X; Ivanova G; Merup M; Jansson M; Stellan B; Grandér D; Zabarovsky E; Gahrton G; Einhorn S
Genomics; 1999 Sep; 60(2):161-71. PubMed ID: 10486207
[TBL] [Abstract][Full Text] [Related]
13. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis.
Bruno E; Horrigan SK; Van Den Berg D; Rozler E; Fitting PR; Moss ST; Westbrook C; Hoffman R
Blood; 1998 Mar; 91(6):1917-23. PubMed ID: 9490674
[TBL] [Abstract][Full Text] [Related]
14. Isolation of yeast artificial chromosomes containing the entire transcriptional unit of the human FGF1 gene: a 720-kb contig spanning human chromosome 5q31.3-->q32.
Chiu IM; Liu Y; Payson RA
Cancer Genet Cytogenet; 1998 Oct; 106(1):1-10. PubMed ID: 9772902
[TBL] [Abstract][Full Text] [Related]
15. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31).
Green WB; Slovak ML; Chen IM; Pallavicini M; Hecht JL; Willman CL
Leukemia; 1999 Dec; 13(12):1960-71. PubMed ID: 10602416
[TBL] [Abstract][Full Text] [Related]
16. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
17. Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms.
Castro PD; Liang JC; Nagarajan L
Blood; 2000 Mar; 95(6):2138-43. PubMed ID: 10706886
[TBL] [Abstract][Full Text] [Related]
18. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31.
Horrigan SK; Arbieva ZH; Xie HY; Kravarusic J; Fulton NC; Naik H; Le TT; Westbrook CA
Blood; 2000 Apr; 95(7):2372-7. PubMed ID: 10733509
[TBL] [Abstract][Full Text] [Related]
19. Physical mapping of the minimal region of loss in 5q- chromosome.
Fairman J; Chumakov I; Chinault AC; Nowell PC; Nagarajan L
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7406-10. PubMed ID: 7638206
[TBL] [Abstract][Full Text] [Related]
20. More detailed characterization of some of the HL60 karyotypic features by fluorescence in situ hybridization.
Volpi EV; Vatcheva R; Labella T; Gan SU
Cancer Genet Cytogenet; 1996 Apr; 87(2):103-6. PubMed ID: 8625253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
